Insider · CIK 0001328625

Mathers Edward T

Reports to the SEC for 18 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001328625

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.4K sh	—	—	22,350
2026-06-04	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2026-06-04	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2026-06-03	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2026-03-12	RYTMRHYTHM PHARMACEUTICALS, INC.J Other	Director	JOther	+4,199 sh	—	—	14,168
2026-03-10	KRROKorro Bio, Inc.P Purchase	10% Owner	PPurchase	+207K sh	$11.11	+$2.3M	1,297,893
2026-03-10	KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase	10% Owner	PPurchase	+243K sh	$11.11	+$2.7M	242,945
2026-03-02	RYTMRHYTHM PHARMACEUTICALS, INC.J Other	Director	JOther	+4,198 sh	—	—	9,969
2026-02-09	SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−738K sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion	10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc.P Purchase	10% Owner	PPurchase	+938K sh	$16.00	+$15M	6,035,038
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+738K sh	—	—	5,097,538
2026-02-09	SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion	10% Owner	CConversion	−1.37M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.62M sh	—	—	0
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.62M sh	—	—	1,619,240
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.37M sh	—	—	4,359,576
2026-02-09	SGPSpyGlass Pharma, Inc.C Conversion	10% Owner	CConversion	+1.37M sh	—	—	2,989,408
2025-12-31	OKUROnKure Therapeutics, Inc.A Award	Director	AAward	+3,911 sh	—	—	15,310
2025-10-02	NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−37.7K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−75K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−124K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−186K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+124K sh	—	—	124,085
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award	Director, 10% Owner	AAward	+186K sh	—	—	186,128
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+608K sh	$0.01	+$6,075.36	2,261,870
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−276 sh	$6.75	−$1,863	674,554
2025-10-02	NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−125K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−608K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+189K sh	$0.01	+$1,891.95	488,982
2025-10-02	NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−100K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+1.66M sh	$0.01	+$16.6K	1,656,789
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−675K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−2.38M sh	—	—	0
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−1.66M sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−2,455 sh	$6.75	−$16.6K	1,654,334
2025-10-02	NEUENeueHealth, Inc.F Tax Payment	Director, 10% Owner	FTax Payment	−182 sh	$6.75	−$1,228.5	2,384,873
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−900 sh	$6.75	−$6,075	2,260,970
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+124K sh	$0.01	+$1,240.85	2,385,055
2025-10-02	NEUENeueHealth, Inc.S Sale	Director, 10% Owner	SSale	−280 sh	$6.75	−$1,890	488,702
2025-10-02	NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−189K sh	—	—	0
2025-10-02	NEUENeueHealth, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+186K sh	$0.01	+$1,861.28	674,830
2025-09-30	OKUROnKure Therapeutics, Inc.A Award	Director	AAward	+4,125 sh	—	—	11,399
2025-06-30	OKUROnKure Therapeutics, Inc.A Award	Director	AAward	+4,694 sh	—	—	7,274
2025-06-25	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	21,950
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,037 sh	—	—	7,037
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,712 sh	—	—	4,712
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	7,000
2025-06-11	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-05	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000

Recent filings

Accepted (ET)
Aug 114
Mathers Edward T0001193125-26-344874
SEC(opens sec.gov)
Jun 84
Mathers Edward T0001193125-26-262279
SEC(opens sec.gov)
Jun 54
Mathers Edward T0001193125-26-259236
SEC(opens sec.gov)
Jun 44
Mathers Edward T0001193125-26-257488
SEC(opens sec.gov)
Mar 164
Mathers Edward T0001193125-26-108351
SEC(opens sec.gov)
Mar 124
Mathers Edward T0001193125-26-104715
SEC(opens sec.gov)
Mar 44
Mathers Edward T0001193125-26-091684
SEC(opens sec.gov)
Feb 114
Mathers Edward T0001193125-26-046664
SEC(opens sec.gov)
Jan 24
Mathers Edward T0001193125-26-000942
SEC(opens sec.gov)
Oct 64
Mathers Edward T0001193125-25-232136
SEC(opens sec.gov)

Companies

Address

104 5TH AVE 19TH FLOOR

NEW YORK, NY, 10011